Year 2 efficacy results of 2 randomized controlled clinical …
Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.
Article, Chapter
Authors:
U.
Publication:
Volume:113,
Page(s):1508.e1
Published:
2006
We were unable to find direct full text links for this item.